메뉴 건너뛰기




Volumn 28, Issue 8, 2012, Pages 582-586

New insights on the pathogenesis of ovarian carcinoma: Molecular basis and clinical implications

Author keywords

ARID1A; BRAF; KRAS; ovarian carcinoma; p53 signature; PTEN; serous tubal intraepithelial carcinoma

Indexed keywords

B RAF KINASE; B RAF KINASE INHIBITOR; BRCA1 PROTEIN; BRCA2 PROTEIN; K RAS PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN P53;

EID: 84863882834     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2011.649595     Document Type: Review
Times cited : (10)

References (77)
  • 1
    • 0033936074 scopus 로고    scopus 로고
    • Ovarian cancer: Epidemiology, biology, and prognostic factors
    • Holschneider CH, Berek JS. Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol 2000;19:3-10.
    • (2000) Semin Surg Oncol , vol.19 , pp. 3-10
    • Holschneider, C.H.1    Berek, J.S.2
  • 3
    • 33244483383 scopus 로고    scopus 로고
    • Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: Revisiting old hypotheses
    • Fleming JS, Beaugié CR, Haviv I, Chenevix-Trench G, Tan OL. Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses. Mol Cell Endocrinol 2006;247:4-21.
    • (2006) Mol Cell Endocrinol , vol.247 , pp. 4-21
    • Fleming, J.S.1    Beaugié, C.R.2    Haviv, I.3    Chenevix-Trench, G.4    Tan, O.L.5
  • 4
    • 0042433449 scopus 로고    scopus 로고
    • New insights regarding pharmacologic approaches for ovarian cancer prevention
    • Rodriguez G. New insights regarding pharmacologic approaches for ovarian cancer prevention. Hematol Oncol Clin North Am 2003;17:1007-20.
    • (2003) Hematol Oncol Clin North Am , vol.17 , pp. 1007-1020
    • Rodriguez, G.1
  • 6
    • 12244271083 scopus 로고    scopus 로고
    • Sex-steroid hormones, gonadotropin and ovarian carcinogenesis: A review of epidemiological and experimental data
    • Gadducci A, Cosio S, Gargini A, Genazzani AR. Sex-steroid hormones, gonadotropin and ovarian carcinogenesis: a review of epidemiological and experimental data. Gynecol Endocrinol 2004;19:216-228.
    • (2004) Gynecol Endocrinol , vol.19 , pp. 216-228
    • Gadducci, A.1    Cosio, S.2    Gargini, A.3    Genazzani, A.R.4
  • 9
    • 0242406722 scopus 로고    scopus 로고
    • Progesterone-induced apoptosis in immortalized normal and malignant human ovarian surface epithelial cells involves enhanced expression of FasL
    • Syed V, Ho SM. Progesterone-induced apoptosis in immortalized normal and malignant human ovarian surface epithelial cells involves enhanced expression of FasL. Oncogene 2003;22:6883-6890.
    • (2003) Oncogene , vol.22 , pp. 6883-6890
    • Syed, V.1    Ho, S.M.2
  • 13
    • 0034652478 scopus 로고    scopus 로고
    • Down-regulation of transforming growth factor β receptors by androgen in ovarian cancer cells
    • Evangelou A, Jindal SK, Brown TJ, Letarte M. Down-regulation of transforming growth factor β receptors by androgen in ovarian cancer cells. Cancer Res 2000;60:929-935.
    • (2000) Cancer Res , vol.60 , pp. 929-935
    • Evangelou, A.1    Jindal, S.K.2    Brown, T.J.3    Letarte, M.4
  • 14
    • 1942469352 scopus 로고    scopus 로고
    • Ovarian tumorigenesis: A proposed model based on morphological and molecular genetic analysis
    • Shih IeM, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 2004;164:1511-1518.
    • (2004) Am J Pathol , vol.164 , pp. 1511-1518
    • Shih, Ie.M.1    Kurman, R.J.2
  • 15
    • 79959328816 scopus 로고    scopus 로고
    • Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-shifting the paradigm
    • Kurman RJ, Shih IeM. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-shifting the paradigm. Hum Pathol 2011;42:918-931.
    • (2011) Hum Pathol , vol.42 , pp. 918-931
    • Kurman, R.J.1    Shih, Ie.M.2
  • 16
    • 77649219639 scopus 로고    scopus 로고
    • The origin and pathogenesis of epithelial ovarian cancer: A proposed unifying theory
    • Kurman RJ, Shih IeM. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 2010;34:433-443.
    • (2010) Am J Surg Pathol , vol.34 , pp. 433-443
    • Kurman, R.J.1    Shih, Ie.M.2
  • 19
    • 10044266232 scopus 로고    scopus 로고
    • Molecular genetic alterations in endometrioid carcinomas of the ovary: Similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas
    • Catasús L, Bussaglia E, Rodrguez I, Gallardo A, Pons C, Irving JA, Prat J. Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas. Hum Pathol 2004;35:1360-1368.
    • (2004) Hum Pathol , vol.35 , pp. 1360-1368
    • Catasús, L.1    Bussaglia, E.2    Rodrguez, I.3    Gallardo, A.4    Pons, C.5    Irving, J.A.6    Prat, J.7
  • 20
    • 65949104847 scopus 로고    scopus 로고
    • Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas
    • Kuo KT, Guan B, Feng Y, Mao TL, Chen X, Jinawath N, Wang Y, et al. Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas. Cancer Res 2009;69:4036-4042.
    • (2009) Cancer Res , vol.69 , pp. 4036-4042
    • Kuo, K.T.1    Guan, B.2    Feng, Y.3    Mao, T.L.4    Chen, X.5    Jinawath, N.6    Wang, Y.7
  • 21
    • 65649128979 scopus 로고    scopus 로고
    • Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma
    • Kuo KT, Mao TL, Jones S, Veras E, Ayhan A, Wang TL, Glas R, et al. Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma. Am J Pathol 2009;174:1597-1601.
    • (2009) Am J Pathol , vol.174 , pp. 1597-1601
    • Kuo, K.T.1    Mao, T.L.2    Jones, S.3    Veras, E.4    Ayhan, A.5    Wang, T.L.6    Glas, R.7
  • 25
    • 83055176483 scopus 로고    scopus 로고
    • The association between endometriosis and ovarian cancer: A review of histological, genetic and molecular alterations
    • Munksgaard PS, Blaakaer J. The association between endometriosis and ovarian cancer: A review of histological, genetic and molecular alterations. Gynecol Oncol 2012;124:164-169.
    • (2012) Gynecol Oncol , vol.124 , pp. 164-169
    • Munksgaard, P.S.1    Blaakaer, J.2
  • 26
    • 41149125616 scopus 로고    scopus 로고
    • Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance
    • Salani R, Kurman RJ, Giuntoli R 2nd, Gardner G, Bristow R, Wang TL, Shih IM. Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance. Int J Gynecol Cancer 2008;18:487-491.
    • (2008) Int J Gynecol Cancer , vol.18 , pp. 487-491
    • Salani, R.1    Kurman, R.J.2    Giuntoli II, R.3    Gardner, G.4    Bristow, R.5    Wang, T.L.6    Shih, I.M.7
  • 27
    • 0037115914 scopus 로고    scopus 로고
    • Homologous repair of DNA damage and tumorigenesis: The BRCA connection
    • Jasin M. Homologous repair of DNA damage and tumorigenesis: the BRCA connection. Oncogene 2002;21:8981-8993.
    • (2002) Oncogene , vol.21 , pp. 8981-8993
    • Jasin, M.1
  • 28
    • 4944229642 scopus 로고    scopus 로고
    • Hallmarks of 'BRCAness' in sporadic cancers
    • Turner N, Tutt A, Ashworth A. Hallmarks of 'BRCAness' in sporadic cancers. Nat Rev Cancer 2004;4:814-819.
    • (2004) Nat Rev Cancer , vol.4 , pp. 814-819
    • Turner, N.1    Tutt, A.2    Ashworth, A.3
  • 29
    • 77958484951 scopus 로고    scopus 로고
    • The genesis and evolution of high-grade serous ovarian cancer
    • Bowell DD. The genesis and evolution of high-grade serous ovarian cancer. Nat Rev Cancer 2010;10:803-808.
    • (2010) Nat Rev Cancer , vol.10 , pp. 803-808
    • Bowell, D.D.1
  • 30
    • 0035175430 scopus 로고    scopus 로고
    • Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer
    • Piek JM, van Diest PJ, Zweemer RP, Jansen JW, Poort-Keesom RJ, Menko FH, Gille JJ, et al. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J Pathol 2001;195:451-456.
    • (2001) J Pathol , vol.195 , pp. 451-456
    • Piek, J.M.1    Van Diest, P.J.2    Zweemer, R.P.3    Jansen, J.W.4    Poort-Keesom, R.J.5    Menko, F.H.6    Gille, J.J.7
  • 31
    • 0033118592 scopus 로고    scopus 로고
    • Control of the cell cycle and apoptosis
    • Lundberg AS, Weinberg RA. Control of the cell cycle and apoptosis. Eur J Cancer 1999;35:531-539.
    • (1999) Eur J Cancer , vol.35 , pp. 531-539
    • Lundberg, A.S.1    Weinberg, R.A.2
  • 32
    • 56449098987 scopus 로고    scopus 로고
    • Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer
    • Gadducci A, Cosio S, Tana R, Genazzani AR. Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer. Crit Rev Oncol Hematol 2009;69:12-27.
    • (2009) Crit Rev Oncol Hematol , vol.69 , pp. 12-27
    • Gadducci, A.1    Cosio, S.2    Tana, R.3    Genazzani, A.R.4
  • 33
    • 70350518233 scopus 로고    scopus 로고
    • Emerging roles of E2Fs in cancer: An exit from cell cycle control
    • Chen HZ, Tsai SY, Leone G. Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer 2009;9:785-797.
    • (2009) Nat Rev Cancer , vol.9 , pp. 785-797
    • Chen, H.Z.1    Tsai, S.Y.2    Leone, G.3
  • 35
    • 69549108233 scopus 로고    scopus 로고
    • Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers
    • Shaw PA, Rouzbahman M, Pizer ES, Pintilie M, Begley H. Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers. Mod Pathol 2009;22:1133-1138.
    • (2009) Mod Pathol , vol.22 , pp. 1133-1138
    • Shaw, P.A.1    Rouzbahman, M.2    Pizer, E.S.3    Pintilie, M.4    Begley, H.5
  • 37
    • 77953126852 scopus 로고    scopus 로고
    • Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase
    • Sehdev AS, Kurman RJ, Kuhn E, Shih IeM. Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase. Mod Pathol 2010;23:844-855.
    • (2010) Mod Pathol , vol.23 , pp. 844-855
    • Sehdev, A.S.1    Kurman, R.J.2    Kuhn, E.3    Shih, Ie.M.4
  • 38
    • 0033617334 scopus 로고    scopus 로고
    • Ordered recruitment of transcription and chromatin remodeling factors to a cell cycle- and developmentally regulated promoter
    • Cosma MP, Tanaka T, Nasmyth K. Ordered recruitment of transcription and chromatin remodeling factors to a cell cycle- and developmentally regulated promoter. Cell 1999;97:299-311.
    • (1999) Cell , vol.97 , pp. 299-311
    • Cosma, M.P.1    Tanaka, T.2    Nasmyth, K.3
  • 42
    • 34248211595 scopus 로고    scopus 로고
    • Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells
    • Zhou W, Han WF, Landree LE, Thupari JN, Pinn ML, Bililign T, Kim EK, et al. Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells. Cancer Res 2007;67:2964-2971.
    • (2007) Cancer Res , vol.67 , pp. 2964-2971
    • Zhou, W.1    Han, W.F.2    Landree, L.E.3    Thupari, J.N.4    Pinn, M.L.5    Bililign, T.6    Kim, E.K.7
  • 44
    • 3643067693 scopus 로고    scopus 로고
    • Induction of a differentiated ciliated cell phenotype in primary cultures of Fallopian tube epithelium
    • Comer MT, Leese HJ, Southgate J. Induction of a differentiated ciliated cell phenotype in primary cultures of Fallopian tube epithelium. Hum Reprod 1998;13:3114-3120.
    • (1998) Hum Reprod , vol.13 , pp. 3114-3120
    • Comer, M.T.1    Leese, H.J.2    Southgate, J.3
  • 45
    • 42949138321 scopus 로고    scopus 로고
    • A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations
    • Folkins AK, Jarboe EA, Saleemuddin A, Lee Y, Callahan MJ, Drapkin R, Garber JE, et al. A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations. Gynecol Oncol 2008;109:168-173.
    • (2008) Gynecol Oncol , vol.109 , pp. 168-173
    • Folkins, A.K.1    Jarboe, E.A.2    Saleemuddin, A.3    Lee, Y.4    Callahan, M.J.5    Drapkin, R.6    Garber, J.E.7
  • 46
    • 33645225423 scopus 로고    scopus 로고
    • The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome
    • Medeiros F, Muto MG, Lee Y, Elvin JA, Callahan MJ, Feltmate C, Garber JE, et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 2006;30:230-236.
    • (2006) Am J Surg Pathol , vol.30 , pp. 230-236
    • Medeiros, F.1    Muto, M.G.2    Lee, Y.3    Elvin, J.A.4    Callahan, M.J.5    Feltmate, C.6    Garber, J.E.7
  • 47
  • 48
    • 77958488424 scopus 로고    scopus 로고
    • The molecular pathogenesis of hereditary ovarian carcinoma: Alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations
    • Norquist BM, Garcia RL, Allison KH, Jokinen CH, Kernochan LE, Pizzi CC, Barrow BJ, et al. The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations. Cancer 2010;116:5261-5271.
    • (2010) Cancer , vol.116 , pp. 5261-5271
    • Norquist, B.M.1    Garcia, R.L.2    Allison, K.H.3    Jokinen, C.H.4    Kernochan, L.E.5    Pizzi, C.C.6    Barrow, B.J.7
  • 49
    • 50849141104 scopus 로고    scopus 로고
    • Early events in the mammalian response to DNA double-strand breaks
    • Riches LC, Lynch AM, Gooderham NJ. Early events in the mammalian response to DNA double-strand breaks. Mutagenesis 2008;23:331-339.
    • (2008) Mutagenesis , vol.23 , pp. 331-339
    • Riches, L.C.1    Lynch, A.M.2    Gooderham, N.J.3
  • 51
    • 24344434551 scopus 로고    scopus 로고
    • Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon
    • Marquez RT, Baggerly KA, Patterson AP, Liu J, Broaddus R, Frumovitz M, Atkinson EN, et al. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Clin Cancer Res 2005;11:6116-6126.
    • (2005) Clin Cancer Res , vol.11 , pp. 6116-6126
    • Marquez, R.T.1    Baggerly, K.A.2    Patterson, A.P.3    Liu, J.4    Broaddus, R.5    Frumovitz, M.6    Atkinson, E.N.7
  • 52
    • 15544374218 scopus 로고    scopus 로고
    • Malignant mixed Mullerian tumor of the fimbriated end of the fallopian tube: Origin as an intraepithelial carcinoma
    • Gagner JP, Mittal K. Malignant mixed Mullerian tumor of the fimbriated end of the fallopian tube: origin as an intraepithelial carcinoma. Gynecol Oncol 2005;97:219-222.
    • (2005) Gynecol Oncol , vol.97 , pp. 219-222
    • Gagner, J.P.1    Mittal, K.2
  • 53
    • 67549148930 scopus 로고    scopus 로고
    • Cystic and adenofibromatous clear cell carcinomas of the ovary: Distinctive tumors that differ in their pathogenesis and behavior: A clinicopathologic analysis of 122 cases
    • Veras E, Mao TL, Ayhan A, Ueda S, Lai H, Hayran M, Shih IeM, Kurman RJ. Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases. Am J Surg Pathol 2009;33:844-853.
    • (2009) Am J Surg Pathol , vol.33 , pp. 844-853
    • Veras, E.1    Mao, T.L.2    Ayhan, A.3    Ueda, S.4    Lai, H.5    Hayran, M.6    Shih, Ie.M.7    Kurman, R.J.8
  • 54
    • 84863869941 scopus 로고    scopus 로고
    • Pathology of malignant and borderline ovarian tumours
    • Ayhan A, Reed N, Gultekin M, Dursun P, Editors. Ankara, Instanbul, Kosuyolu: Gunes Publishing
    • Singh N. Pathology of malignant and borderline ovarian tumours. In: Ayhan A, Reed N, Gultekin M, Dursun P, Editors. "Textbook of Gynaecological Oncology". Ankara, Instanbul, Kosuyolu: Gunes Publishing; 2012. pp 333-338.
    • (2012) Textbook of Gynaecological Oncology , pp. 333-338
    • Singh, N.1
  • 55
    • 58349090850 scopus 로고    scopus 로고
    • Endometriosis
    • Bulun SE. Endometriosis. N Engl J Med 2009;360:268-279.
    • (2009) N Engl J Med , vol.360 , pp. 268-279
    • Bulun, S.E.1
  • 56
    • 0030717451 scopus 로고    scopus 로고
    • Cancer and endometriosis: Do we need to be concerned?
    • Martin DC. Cancer and endometriosis: do we need to be concerned? Semin Reprod Endocrinol 1997;15:319-324.
    • (1997) Semin Reprod Endocrinol , vol.15 , pp. 319-324
    • Martin, D.C.1
  • 57
    • 0029844126 scopus 로고    scopus 로고
    • Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy
    • The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives
    • Rosenblatt KA, Thomas DB. Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Cancer Epidemiol Biomarkers Prev 1996;5:933-935.
    • (1996) Cancer Epidemiol Biomarkers Prev , vol.5 , pp. 933-935
    • Rosenblatt, K.A.1    Thomas, D.B.2
  • 58
    • 84863874226 scopus 로고    scopus 로고
    • The Origin and pathogenesis of epithelial ovarian cancer
    • Ayhan A, Reed N, Gultekin M, Dursun P, Editors. Ankara, Instanbul, Kosuyolu: Gunes Publishing
    • Banet N, Shih IeM, Kurman RJ. The Origin and pathogenesis of epithelial ovarian cancer. In: Ayhan A, Reed N, Gultekin M, Dursun P, Editors. "Textbook of Gynaecological Oncology". Ankara, Instanbul, Kosuyolu: Gunes Publishing; 2012. pp 422-428.
    • (2012) Textbook of Gynaecological Oncology , pp. 422-428
    • Banet, N.1    Shih, Ie.M.2    Kurman, R.J.3
  • 59
    • 34447336446 scopus 로고    scopus 로고
    • Ovarian mucinous tumors associated with mature cystic teratomas: Morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary
    • Vang R, Gown AM, Zhao C, Barry TS, Isacson C, Richardson MS, Ronnett BM. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary. Am J Surg Pathol 2007;31:854-869.
    • (2007) Am J Surg Pathol , vol.31 , pp. 854-869
    • Vang, R.1    Gown, A.M.2    Zhao, C.3    Barry, T.S.4    Isacson, C.5    Richardson, M.S.6    Ronnett, B.M.7
  • 60
    • 84863881303 scopus 로고    scopus 로고
    • Molecular basis of gynecologic cancers
    • Ayhan A, Reed N, Gultekin M, Dursun P, Editors. Ankara, Instanbul, Kosuyolu: Gunes Publishing
    • Vaknin Z, Gotlieb WH. Molecular basis of gynecologic cancers. In: Ayhan A, Reed N, Gultekin M, Dursun P, Editors. "Textbook of Gynaecological Oncology". Ankara, Instanbul, Kosuyolu: Gunes Publishing; 2012. pp 183-190.
    • (2012) Textbook of Gynaecological Oncology , pp. 183-190
    • Vaknin, Z.1    Gotlieb, W.H.2
  • 61
    • 4944250783 scopus 로고    scopus 로고
    • Mutations of BRAF and KRAS precede the development of ovarian serous borderline tumors
    • Ho CL, Kurman RJ, Dehari R, Wang TL, Shih IeM. Mutations of BRAF and KRAS precede the development of ovarian serous borderline tumors. Cancer Res 2004;64:6915-6918.
    • (2004) Cancer Res , vol.64 , pp. 6915-6918
    • Ho, C.L.1    Kurman, R.J.2    Dehari, R.3    Wang, T.L.4    Shih, Ie.M.5
  • 62
    • 80155131218 scopus 로고    scopus 로고
    • ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers
    • Guan B, Wang TL, Shih IeM. ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. Cancer Res 2011;71:6718-6727.
    • (2011) Cancer Res , vol.71 , pp. 6718-6727
    • Guan, B.1    Wang, T.L.2    Shih, Ie.M.3
  • 63
    • 34347347175 scopus 로고    scopus 로고
    • The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: A morphologic and molecular genetic analysis
    • Dehari R, Kurman RJ, Logani S, Shih IeM. The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis. Am J Surg Pathol 2007;31:1007-1012.
    • (2007) Am J Surg Pathol , vol.31 , pp. 1007-1012
    • Dehari, R.1    Kurman, R.J.2    Logani, S.3    Shih, Ie.M.4
  • 69
    • 77955415712 scopus 로고    scopus 로고
    • PARP inhibition: Targeting the Achilles'heel of DNA repair to treat germline and sporadic ovarian cancers
    • Carden CP, Yap TA, Kaye SB. PARP inhibition: targeting the Achilles'heel of DNA repair to treat germline and sporadic ovarian cancers. Curr Opin Oncol 2010;22:473-480.
    • (2010) Curr Opin Oncol , vol.22 , pp. 473-480
    • Carden, C.P.1    Yap, T.A.2    Kaye, S.B.3
  • 70
    • 78149370970 scopus 로고    scopus 로고
    • The emerging role of PARP inhibitors in the treatment of epithelial ovarian cancer
    • Gien LT, Mackay HJ. The emerging role of PARP inhibitors in the treatment of epithelial ovarian cancer. J Oncol 2010;2010:151750.
    • (2010) J Oncol , vol.2010 , pp. 151750
    • Gien, L.T.1    Mackay, H.J.2
  • 71
    • 80053135643 scopus 로고    scopus 로고
    • Phase II randomized placebo- controlled study of olaparib (AZD2281) in patients with platinum-sensitive relapsed serous ovarian cancer (PSR SOC)
    • Abstract 5003
    • Ledermann JA. Phase II randomized placebo- controlled study of olaparib (AZD2281) in patients with platinum-sensitive relapsed serous ovarian cancer (PSR SOC). J Clin Oncol 2011;29 (issue 15S): Abstract 5003.
    • (2011) J Clin Oncol , vol.29 , Issue.15 S
    • Ledermann, J.A.1
  • 73
    • 84857475389 scopus 로고    scopus 로고
    • Loss of BRCA1 protein expression as indicator of the BRCAness phenotype is associated with favorable overall survival after complete resection of sporadic ovarian cancer
    • Radosa MP, Häfner N, Camara O, Diebolder H, Mothes A, Winzer H, Jansen L, et al. Loss of BRCA1 protein expression as indicator of the BRCAness phenotype is associated with favorable overall survival after complete resection of sporadic ovarian cancer. Int J Gynecol Cancer 2011;21:1399-1406.
    • (2011) Int J Gynecol Cancer , vol.21 , pp. 1399-1406
    • Radosa, M.P.1    Häfner, N.2    Camara, O.3    Diebolder, H.4    Mothes, A.5    Winzer, H.6    Jansen, L.7
  • 74
    • 80054765897 scopus 로고    scopus 로고
    • Assays for hypermethylation of the BRCA1 gene promoter in tumor cells to predict sensitivity to PARP-inhibitor therapy
    • Ibragimova I, Cairns P. Assays for hypermethylation of the BRCA1 gene promoter in tumor cells to predict sensitivity to PARP-inhibitor therapy. Methods Mol Biol 2011;780:277-291.
    • (2011) Methods Mol Biol , vol.780 , pp. 277-291
    • Ibragimova, I.1    Cairns, P.2
  • 75
    • 38649099966 scopus 로고    scopus 로고
    • KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab
    • Lièvre A, Bachet JB, Boige V, Cayre A, Le Corre D, Buc E, Ychou M, et al. KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab. J Clin Oncol 2008;26:374-379.
    • (2008) J Clin Oncol , vol.26 , pp. 374-379
    • Lièvre, A.1    Bachet, J.B.2    Boige, V.3    Cayre, A.4    Le Corre, D.5    Buc, E.6    Ychou, M.7
  • 76
    • 33846483745 scopus 로고    scopus 로고
    • EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: Retro- and prospective observations in non-small-cell lung cancer
    • van Zandwijk N, Mathy A, Boerrigter L, Ruijter H, Tielen I, de Jong D, Baas P, et al. EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small-cell lung cancer. Ann Oncol 2007;18:99-103.
    • (2007) Ann Oncol , vol.18 , pp. 99-103
    • Van Zandwijk, N.1    Mathy, A.2    Boerrigter, L.3    Ruijter, H.4    Tielen, I.5    De Jong, D.6    Baas, P.7
  • 77
    • 51749099175 scopus 로고    scopus 로고
    • The emerging role of epidermal growth factor receptor inhibitors in ovarian cancer
    • Palayekar MJ, Herzog TJ. The emerging role of epidermal growth factor receptor inhibitors in ovarian cancer. Int J Gynecol Cancer 2008;18:879-890.
    • (2008) Int J Gynecol Cancer , vol.18 , pp. 879-890
    • Palayekar, M.J.1    Herzog, T.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.